Medacta Group SA
SIX:MOVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chin Teck Plantations Bhd
KLSE:CHINTEK
|
MY |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
Innotech Corp
TSE:9880
|
JP |
|
N
|
Norconsult ASA
OSE:NORCO
|
NO |
|
XP Factory PLC
LSE:XPF
|
UK |
|
Xinyi Energy Holdings Ltd
HKEX:3868
|
CN |
|
A
|
Al Jouf Cement Company SJSC
SAU:3091
|
SA |
|
Jindal Steel And Power Ltd
NSE:JINDALSTEL
|
IN |
|
O
|
Oizumi Corp
TSE:6428
|
JP |
|
Dong Il Steel MFG Co Ltd
KRX:002690
|
KR |
|
Cybertrust Japan Co Ltd
TSE:4498
|
JP |
|
ADC Therapeutics SA
NYSE:ADCT
|
CH |
|
Musashi Seimitsu Industry Co Ltd
TSE:7220
|
JP |
Medacta Group SA
Total Current Liabilities
Medacta Group SA
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Medacta Group SA
SIX:MOVE
|
Total Current Liabilities
€216.7m
|
CAGR 3-Years
35%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Total Current Liabilities
CHf46.4m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
|
|
Sonova Holding AG
SIX:SOON
|
Total Current Liabilities
CHf1.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Straumann Holding AG
SIX:STMN
|
Total Current Liabilities
CHf743.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Medmix Ltd
SIX:MEDX
|
Total Current Liabilities
CHf171.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Medacta Group SA
Glance View
Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.
See Also
What is Medacta Group SA's Total Current Liabilities?
Total Current Liabilities
216.7m
EUR
Based on the financial report for Dec 31, 2025, Medacta Group SA's Total Current Liabilities amounts to 216.7m EUR.
What is Medacta Group SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
8%
Over the last year, the Total Current Liabilities growth was 38%. The average annual Total Current Liabilities growth rates for Medacta Group SA have been 35% over the past three years , 8% over the past five years .